Preview

Problems of Particularly Dangerous Infections

Advanced search

Construction of Polymeric Antigenic Diagnosticum Based on Vibrio cholera О1 Lipopolysaccharide

https://doi.org/10.21055/0370-1069-2019-4-67-72

Abstract

Representatives of the genus Vibrio cholerae differ in the structure of lipopolysaccharide, in particular, its O-polysaccharide chains (O-antigen), which determines the serological specificity of vibrios. Currently, the water-phenolic method is used to obtain the lipopolysaccharide preparation. However, this technique relates to harsh chemical methods, leads to a change in original molecular organization of biopolymer, violating its structure and biological properties. Modern technologies in the development of diagnostic kits for the immunosuspension reaction of volume agglomeration allow for obtaining synthetic carriers with different reaction groups on the particle surface capable to bind antigens/antibodies. The aim of this study was to construct cholera antigenic polymeric diagnostic kit based on the lipopolysaccharide of Vibrio cholerae O1 serogroup. Materials and methods. The lipopolysaccharide was used as a sensitizer obtained through the author's modification of enzymatic purification from the cell membranes of Vibrio cholerae using ultrasonic disintegration. Results and discussion. The resulting sensitin contains small impurities of protein (1.5 %) and nucleic acids (0.1 %). Diagnosticum is characterized by high analytical sensitivity in agglomeration reaction with commercial and experimental rabbit serum to Vibrio cholerae O1 serogroup (1:640 - 1:5120) and analytical specificity (the diagnosticum does not interact with heterologous sera, with serums to pathogens of acute intestinal infections, as well as with sera from healthy donors). A polymeric antigenic cholera diagnosticum designed to detect antibodies to lipopolysaccharide of Vibrio cholerae in the blood serum of patients who were ill, suspected of the disease or vaccinated people has been constructed.

About the Authors

L. V. Larionova
Rostov-on-Don Research Anti-Plague Institute
Russian Federation

Lydmila V. Larionova.

117/40, M.Gor'kogo St., Rostov-on-Don, 344002.



D. I. Simakova
Rostov-on-Don Research Anti-Plague Institute
Russian Federation

117/40, M.Gor'kogo St., Rostov-on-Don, 344002.



A. N. Narkevich
Rostov-on-Don Research Anti-Plague Institute
Russian Federation

117/40, M.Gor'kogo St., Rostov-on-Don, 344002.



I. V. Arkhangel’skaya
Rostov-on-Don Research Anti-Plague Institute
Russian Federation

117/40, M.Gor'kogo St., Rostov-on-Don, 344002.



G. G. Shubin
Rostov-on-Don Research Anti-Plague Institute
Russian Federation

117/40, M.Gor'kogo St., Rostov-on-Don, 344002.



References

1. Faruque S.M., Albert M.J., Mekalanos J.J. Epidemiology, genetics and ecology of toxigenic Vibrio cholerae. Microbiol. Molecul. Biol. Rev. 1998; 62(4):1301-14. PMID: 9841673. PMCID: PMC98947.

2. Gyulazayn N.M., Belaya O.F., Malov V.A., Pak S.G., Volchakova E.V. [Lipopolysaccharides/endotoxins of gram-negative bacteria: role in intoxication development]. Epidemiologiya I Infektsionnye Bolezni [Epidemiology and Infectious Diseases]. 2014; 19(2):11–6.

3. Leung D.T., Uddin T., Xu P., AktarA., Johnson R.A., Rahman M.A., Alam M.M., Bufalo M.K., Eckhoff G., Wu-Freeman Y, Yu Y, Sultana T., Khanam F., Saha A., Chowdhury F., Khan A.I., Charles R.C., LaRocque R.C., Harris J.B., Calderwood S.B., Covac P, Qadri F., Ryan E.T. Immune responses to the O-specific polysaccharide an¬tigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin. Vaccine Immunol. 2013; 20(6):780-8. DOI: 10.1128/CVI.00035-13.

4. Uddin T., Aktar A., Xu P, Johnson R.A., Rahman M.A., Leung D.T., Afrin S., Akter A., Alam M.M., Rahman A., Chowdhuty F., Khan A.I., Bhuiyan T.R., Bufano M.K., Rashu R., Yu Y, Wu-Freeman Y, Harris J.B., LaRocque R.C., Charles R.C., Covac P, Calderwood S.B., Ryan E.T., Qadri F. Immune responses to O-spesific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed vaccine and com¬parison to responses in patients with cholera. Am. J. Trop. Med. Hyg. 2014; 90(5):873-81. DOI: 10.4269/ajtmh.13-0498.

5. Darveau R.P., Hancock R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella thyphimurium strains. J. Bacteriol. 1983; 155(2):831-8. PMID: 6409884. PMCID: PMC217756.

6. Polunina T.A., Guseva N.P., Kuz’michenko I.A., Devdariani Z.L Zadnova S.P., Stepanov A.V., Kireev M.N. [Method for the production of lipopolysaccharide of plague agent]. RF Patent No 2483112, published on May 27, 2013.

7. Markov E.Yu., Nikolaev V.B. [Method for the production of bacterial lipopolysaccharides]. RF Patent No 2051969, published on January 10, 1Э96. Bulletin No 1.

8. Westphal V.O., Luderitz O., Bister F. Uber die Extraktion von Bacterien mit Phenol/Wasser. Zeitschrift fur Naturforschung B. 1952; 7(34:148-55. DOI: 10.1515/znb-1952-0303.

9. Galanos C., Luderitz O., Westphal O. A New method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 1969; 9(2):245-9. DOI: 10.1111/j.1432-1033.1969.tb00601.x.

10. Lomov Yu.M., Terent’ev A.N., Karbyshev G.L. [Prospects of creation of preparations for indication of particularly dangerous infections agents and other relevant infections]. In: [Proceedings of the IX Assembly of the All-Russian Scientific-and-Practical Society of Epidemiologists, Microbiologists, and Parasitologists]. Moscow: “Sanepidemiya” LLC; 2007. P. 60-1.

11. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Dangerous infectious Diseases. Practice Guidelines]. 2nd edition, revised and updated. Moscow: CJSC “Shiko”; 2013. 560 p.

12. Lowry O.H., Rosebrough N.J. Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193(1):265-75.

13. [Determination of nucleic acids in immunobiological drugs, using Spirin’s methodology. General Monograph 1.7.2.0018.15]. (Cited 15 June 2019). [Internet]. Available from: https://pharmacopoeia.ru/ofs-1-7-2-0018-15-opredelenie-nukleinovyh-kislot-po-metodu-spirina-v-immunobiologicheskih-lekarstvennyh-preparatah/ofs-1-7-2-0018-15-opredelenie-nukleinovyh-kislot-po-metodu-spirina-v-immunobiologicheskih-lekarstvennyh-preparatah/.

14. Laemmli U.K. Cleavage of structural proteins during assembly of head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0/.

15. Ramamurthy T., Das B., Chakraborty S., Mukhopadhyay A.K., Sack D.A. Diagnostic techniques for rapid detection of Vibrio cholerae O1/O139. Vaccine. 2019; pii: S0264-410X(19)31020-5. DOI: 10.1016/j.vaccine.2019.07.099.

16. Vlasov V.V. [Epidemiology: Learning Guide for Higher Educational Institutions]. Moscow: “GEOTAR-MED”; 2006. 462 p.


Review

For citations:


Larionova L.V., Simakova D.I., Narkevich A.N., Arkhangel’skaya I.V., Shubin G.G. Construction of Polymeric Antigenic Diagnosticum Based on Vibrio cholera О1 Lipopolysaccharide. Problems of Particularly Dangerous Infections. 2019;(4):67-72. (In Russ.) https://doi.org/10.21055/0370-1069-2019-4-67-72

Views: 773


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)